Total Costs & Expenses

$824.60M

TTM · Period ending: Jun 30, 2026 · USD

EBS Total Costs & Expenses

Latest reported$824.60Mperiod endingJun 30, 2026

EBS TTM Total Costs & Expenses ($1.87B → $824.60M)

TTM Total Costs & Expenses

High-resolution chart · PNG

EBS total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Emergent Biosolutions Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period ending	Total Costs & Expenses (USD)
Jun 30, 2026	824,600,000
Mar 31, 2026	605,600,000
Dec 31, 2025	633,600,000
Sep 30, 2025	672,500,000
Jun 30, 2025	747,500,000
Mar 31, 2025	1,065,300,000
Dec 31, 2024	1,152,300,000
Sep 30, 2024	1,268,500,000
Jun 30, 2024	1,551,800,000
Mar 31, 2024	1,724,400,000
Dec 31, 2023	1,775,700,000
Sep 30, 2023	1,840,800,000
Jun 30, 2023	1,613,400,000
Mar 31, 2023	1,298,300,000
Dec 31, 2022	1,287,500,000
Sep 30, 2022	1,347,800,000
Jun 30, 2022	1,426,300,000
Mar 31, 2022	1,493,600,000
Dec 31, 2021	1,440,100,000
Sep 30, 2021	1,319,200,000
Jun 30, 2021	1,279,400,000
Mar 31, 2021	1,165,100,000
Dec 31, 2020	1,121,600,000
Sep 30, 2020	1,055,200,000
Jun 30, 2020	972,400,000
Mar 31, 2020	953,900,000
Dec 31, 2019	967,600,000
Sep 30, 2019	968,600,000
Jun 30, 2019	879,800,000
Mar 31, 2019	783,000,000
Dec 31, 2018	692,500,000
Sep 30, 2018	573,744,000
Jun 30, 2018	523,109,000
Mar 31, 2018	461,952,000
Dec 31, 2017	436,600,000
Sep 30, 2017	396,590,000
Jun 30, 2017	402,361,000
Mar 31, 2017	403,400,999
Dec 31, 2016	383,259,999
Sep 30, 2016	377,163,999
Jun 30, 2016	364,946,999
Mar 31, 2016	337,681,000
Dec 31, 2015	347,817,000
Sep 30, 2015	356,534,000
Jun 30, 2015	368,237,000
Mar 31, 2015	404,683,000
Dec 31, 2014	392,082,000
Sep 30, 2014	363,541,000
Jun 30, 2014	327,516,000
Mar 31, 2014	292,759,000
Dec 31, 2013	269,850,000
Sep 30, 2013	265,381,999
Jun 30, 2013	251,275,999
Mar 31, 2013	245,295,999
Dec 31, 2012	242,111,999
Sep 30, 2012	233,724,000
Jun 30, 2012	234,287,000
Mar 31, 2012	240,495,000
Dec 31, 2011	241,285,000
Sep 30, 2011	247,611,000
Aug 3, 2011	243,638,000
Mar 31, 2011	223,031,000
Dec 31, 2010	212,614,000
Sep 30, 2010	194,009,000
Jun 30, 2010	187,851,000
Mar 31, 2010	191,005,000
Dec 31, 2009	194,636,000
Sep 30, 2009	179,853,000
Jun 30, 2009	173,891,000
Mar 31, 2009	164,337,000
Dec 31, 2008	148,629,000
Sep 30, 2008	160,212,000
Jun 30, 2008	158,173,000
Mar 31, 2008	149,089,000
Dec 31, 2007	149,823,000
Sep 30, 2007	146,334,000
Jun 30, 2007	130,858,000
Mar 31, 2007	99,015,000
Dec 31, 2006	66,736,000
Sep 30, 2006	-59,031,000
Jun 30, 2006	-82,777,000
Mar 31, 2006	-82,777,000
Dec 31, 2005	-82,777,000
Sep 30, 2005	-70,542,000
Jun 30, 2005	-70,542,000
Mar 31, 2005	-70,542,000
Dec 31, 2004	-70,542,000
Sep 30, 2004	395,800,000
Jun 30, 2004	862,700,000
Mar 31, 2004	1,493,500,000
Dec 31, 2001	1,874,900,000
Sep 30, 2001	1,874,900,000